Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Web Exclusives
Drug Updates
,
FDA Approvals
,
Select Drug Profiles
Onivyde (Irinotecan Liposome Injection) a New Treatment Option for Patients with Metastatic Pancreatic Cancer
Read More
FDA Approvals
,
In the News
,
Select Drug Profiles
FDA Approves First Seasonal Influenza Vaccine Containing an Adjuvant
Read More
FDA Approvals
,
In the News
,
Select Drug Profiles
FDA Approves Bridion to Reverse Effects of Neuromuscular Blocking Drugs Used During Surgery
Read More
FDA Approvals
,
In the News
,
Select Drug Profiles
FDA Approves First Emergency Treatment for Overdose of Certain Types of Chemotherapy
Read More
FDA Approvals
,
In the News
,
Select Drug Profiles
FDA Approves New Oral Therapy to Treat ALK-Positive Lung Cancer
Read More
FDA Approvals
,
In the News
,
Select Drug Profiles
FDA Approves Empliciti, a New Immune-Stimulating Therapy to Treat Multiple Myeloma
Read More
FDA Moves Quickly to Approve Easy-to-Use Nasal Spray to Treat Opioid Overdose
Read More
FDA Approves Ninlaro, New Oral Medication to Treat Multiple Myeloma
Read More
FDA Approves Darzalex for Patients with Previously Treated Multiple Myeloma
Read More
FDA Approves New Pill to Treat Certain Patients with Non—Small-Cell Lung Cancer
Read More
22
23
24
25
26
27
28
Page 25 of 37
Results 241 - 250 of 367